Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entecavir vs other nucleos(t)ide analogues in chronic hepatitis B
CTR20132358Phase 4Active
- Sponsor
- Sino-American Shanghai Squibb Pharmaceuticals
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of entecavir in Chronic Hepatitis B (CHB), sponsored by Sino-American Shanghai Squibb Pharmaceuticals. Started Jan 2014; status: active.
02
Drugs
entecavir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on CTR20132358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132358.